Translational Research Institute embarks on next growth phase: A leading medical research institute is creating more connections for scientists, clinicians and industry through an outstanding ecosystem and facilities.

The article focuses on the Translational Research Institute's (TRI) expansion and its impact on advancing biomedical research and manufacturing in Australia. It highlights TRI's collaboration with Microbio to address challenges in scaling up production and securing sovereign manufacturing capabilities, as well as the upcoming TM@TRI facility, which aims to support emerging biotechs and medtechs by providing critical manufacturing infrastructure and fostering end-to-end research collaboration.